Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Sonoma Pharmaceuticals, Inc. SNOA

Set alert

Price alert · SNOA

All alert types
1.10 USD -0.10 -8.33%

At close · Oct 30

1.10 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
1.07 × 2
Ask
1.10 × 2
1.07 Day range 1.17
1.01 52-week range 3.95
YTD
-69.78%
1 year
-72.15%
Open
1.16
Prev close
1.20
Mkt cap
5.27M
Vol
85.81K
Avg vol
106.86K
EPS
-1.22
P/E
0.00
Div yield
0.00%
More statistics
Low
1.07
High
1.17
Forward P/E
-1.49
Beta
1.38
Short ratio
0.22
Inst. own
2.42%
Dividend
0.00
Ex-div date
Earnings
Feb 13, 2025
50-d avg
2.82
200-d avg
3.79
1y target
19.50

5D chart

Chart tools
Interval
1m5m15m30m

Signals (9)
NameTimeAgo
SMA: BearishOct 30, 9:30 AM1 day ago
MACD: Sell SignalOct 30, 9:30 AM1 day ago
MACD: Buy SignalOct 29, 3:55 PM2 days ago
MACD: Sell SignalOct 29, 2:30 PM2 days ago
SMA: BullishOct 29, 9:35 AM2 days ago
SMA: BearishOct 28, 3:55 PM3 days ago
SMA: BearishOct 28, 9:30 AM3 days ago
SMA: BearishOct 28, 9:30 AM3 days ago
SMA: BullishOct 26, 3:50 PM5 days ago

Financial health

Altman Z-Score

-13.67 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 5

Valuation

P/E -1.1×
FY 2017: 6.5×FY 2018: -2.3×FY 2019: -1.3×FY 2020: -4.4×FY 2021: -6.3×FY 2022: -4.2×FY 2023: -1.3×FY 2024: -0.6×FY 2025: -0.8×FY 2026: -1.1×
FY 2017 5y median -1.1× FY 2026
P/S 0.2×
FY 2017: 4.7×FY 2018: 2.0×FY 2019: 0.8×FY 2020: 0.8×FY 2021: 1.6×FY 2022: 1.7×FY 2023: 0.5×FY 2024: 0.2×FY 2025: 0.2×FY 2026: 0.2×
FY 2017 5y median 0.2× FY 2026
P/B 1.2×
FY 2017: 2.8×FY 2018: 2.2×FY 2019: 1.5×FY 2020: 2.6×FY 2021: 5.5×FY 2022: 2.4×FY 2023: 0.8×FY 2024: 0.5×FY 2025: 0.6×FY 2026: 1.2×
FY 2017 5y median 0.8× FY 2026
P/FCF -0.9×
FY 2017: -7.1×FY 2018: -2.6×FY 2019: -1.3×FY 2020: -3.0×FY 2021: -8.3×FY 2022: -4.9×FY 2023: -1.0×FY 2024: -1.2×FY 2025: -16.2×FY 2026: -0.9×
FY 2017 5y median -1.2× FY 2026
EV/EBITDA -0.9×
FY 2017: -3.4×FY 2018: -1.7×FY 2019: -1.1×FY 2020: -3.6×FY 2021: -8.7×FY 2022: -2.9×FY 2023: -0.7×FY 2024: -0.1×FY 2025: 0.8×FY 2026: -0.9×
FY 2017 5y median -0.7× FY 2026
EV/Sales 0.1×
FY 2017: 3.4×FY 2018: 1.4×FY 2019: 0.6×FY 2020: 0.6×FY 2021: 1.5×FY 2022: 1.2×FY 2023: 0.3×FY 2024: 0.0×FY 2025: -0.2×FY 2026: 0.1×
FY 2017 5y median 0.1× FY 2026
FCF Yield -115.0%
FY 2017: -14.1%FY 2018: -37.9%FY 2019: -77.2%FY 2020: -33.1%FY 2021: -12.0%FY 2022: -20.6%FY 2023: -96.9%FY 2024: -86.8%FY 2025: -6.2%FY 2026: -115.0%
FY 2017 5y median -86.8% FY 2026

Profitability

Gross Margin 38.0%
FY 2017: 44.2%FY 2018: 43.9%FY 2019: 46.8%FY 2020: 45.3%FY 2021: 35.2%FY 2022: 31.6%FY 2023: 33.7%FY 2024: 37.3%FY 2025: 38.2%FY 2026: 38.0%
FY 2017 5y median 37.3% FY 2026
Operating Margin -12.6%
FY 2017: -101.2%FY 2018: -85.2%FY 2019: -59.3%FY 2020: -41.2%FY 2021: -18.5%FY 2022: -46.6%FY 2023: -34.4%FY 2024: -36.9%FY 2025: -26.0%FY 2026: -12.6%
FY 2017 5y median -34.4% FY 2026
Net Margin -16.3%
FY 2017: 72.3%FY 2018: -86.0%FY 2019: -62.2%FY 2020: -18.5%FY 2021: -21.2%FY 2022: -40.3%FY 2023: -38.8%FY 2024: -38.0%FY 2025: -24.2%FY 2026: -16.3%
FY 2017 5y median -38.0% FY 2026
ROE -102.6%
FY 2017: 43.3%FY 2018: -93.5%FY 2019: -112.5%FY 2020: -58.8%FY 2021: -73.7%FY 2022: -58.5%FY 2023: -64.6%FY 2024: -78.8%FY 2025: -78.4%FY 2026: -102.6%
FY 2017 5y median -78.4% FY 2026
ROIC -24.1%
FY 2017: -38.9%FY 2018: -86.9%FY 2019: -99.5%FY 2020: -70.7%FY 2021: -29.4%FY 2022: -39.2%FY 2023: -34.4%FY 2024: -39.1%FY 2025: -37.6%FY 2026: -24.1%
FY 2017 5y median -37.6% FY 2026
ROA -22.7%
FY 2017: 36.4%FY 2018: -74.6%FY 2019: -81.7%FY 2020: -22.7%FY 2021: -26.4%FY 2022: -27.0%FY 2023: -31.7%FY 2024: -32.8%FY 2025: -25.2%FY 2026: -22.7%
FY 2017 5y median -27.0% FY 2026

Growth (YoY)

Revenue 36.7%
FY 2017: 36.9%FY 2018: 29.9%FY 2019: 13.9%FY 2020: -5.5%FY 2021: 3.9%FY 2022: -32.2%FY 2023: 5.1%FY 2024: -4.0%FY 2025: 12.2%FY 2026: 36.7%
FY 2017 FY 2026
Operating Income 33.7%
FY 2017: 11.8%FY 2018: -9.4%FY 2019: 20.7%FY 2020: 34.4%FY 2021: 53.3%FY 2022: -70.7%FY 2023: 22.4%FY 2024: -2.9%FY 2025: 21.1%FY 2026: 33.7%
FY 2017 FY 2026
EPS (diluted) 32.3%
FY 2017: 267.7%FY 2018: -244.1%FY 2019: 55.1%FY 2020: 82.5%FY 2021: -5.6%FY 2022: 18.9%FY 2023: 20.8%FY 2024: 65.0%FY 2025: 47.6%FY 2026: 32.3%
FY 2017 FY 2026
Free Cash Flow -2355.4%
FY 2017: 5.8%FY 2018: -47.5%FY 2019: 6.4%FY 2020: 59.4%FY 2021: 25.8%FY 2022: -23.3%FY 2023: -46.4%FY 2024: 62.4%FY 2025: 93.0%FY 2026: -2355.4%
FY 2017 FY 2026

Financial Health

Current Ratio 2.5×
FY 2017: 6.9×FY 2018: 5.0×FY 2019: 3.5×FY 2020: 2.6×FY 2021: 3.1×FY 2022: 2.8×FY 2023: 3.7×FY 2024: 3.4×FY 2025: 3.1×FY 2026: 2.5×
FY 2017 5y median 3.1× FY 2026
Quick Ratio 1.7×
FY 2017: 6.2×FY 2018: 4.1×FY 2019: 2.5×FY 2020: 2.2×FY 2021: 2.5×FY 2022: 2.4×FY 2023: 2.9×FY 2024: 2.6×FY 2025: 2.4×FY 2026: 1.7×
FY 2017 5y median 2.4× FY 2026
Debt / Equity 0.3×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.2×FY 2021: 0.5×FY 2022: 0.2×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.1×FY 2026: 0.3×
FY 2017 5y median 0.1× FY 2026
Net Debt / EBITDA 0.7×
FY 2017: 1.3×FY 2018: 0.7×FY 2019: 0.3×FY 2020: 0.9×FY 2021: 0.5×FY 2022: 1.2×FY 2023: 0.6×FY 2024: 0.5×FY 2025: 1.8×FY 2026: 0.7×
FY 2017 5y median 0.7× FY 2026
Interest Coverage 0.0×
FY 2017: -4325×FY 2018: -355×FY 2019: -341×FY 2020: -462×FY 2021: -287×FY 2022: -589×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-03-31